Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
Thymalin (THYM) is a immune peptide, at the approved in russia stage in the published literature. Bovine thymus extract containing multiple thymic peptides including thymulin. Used in Russia for immune modulation.
Bovine thymus extract containing multiple thymic peptides including thymulin. Used in Russia for immune modulation.
| Research Status | Approved in Russia |
|---|---|
| Half-Life | Variable |
| Administration | Intramuscular injection |
| Doses Reported in Published Studies | 10 mg daily |
Complex of thymic peptides that restore immune function and thymus activity.
Bovine thymus extract containing multiple thymic peptides including thymulin. Used in Russia for immune modulation.
Complex of thymic peptides that restore immune function and thymus activity.
Thymalin is at the following stage in the published literature: Approved in Russia. All information is for research and educational purposes only.
Reported half-life: Variable.
Reported administration route in the literature: Intramuscular injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.